Abbott Laboratories (ABT)
ABT Price and Sentiment
ABT Latest news
Abbott (ABT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Is (ABT) Outperforming Other Medical Stocks This Year?
Both are great places to park your money for years.
Within Nutrition, the robust year-over-year performance of Abbott's (ABT) U.S. pediatric and international adult nutrition arms drives the company in the third quarter.
There was nothing but good news for Abbott in Q3.
All four of the company's divisions posted strong growth, but one in particular was a standout.
On Wednesday, Abbott Laboratories (NYSE:ABT) shares surged nearly 4% after announcing solid fiscal third-quarter results. The company reported its most recent quarterly revenue and earnings before markets opened, beating the consensus Street expectations.
Abbott Laboratories (ABT) CEO Robert Ford on Q3 2021 Results - Earnings Call Transcript
Abbott's (ABT) COVID-19 testing-related sales in Q3 increase on demand for BinaxNOW, Panbio and ID NOW rapid testing platforms.